Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
published in: Chemistry and Biology
date of publication: 2015-08-27
Cites articles 54
Date
Title
Article - wd:Q36084130
Article - wd:Q36084130